United States

People: Procter & Gamble Co (PG.N)

PG.N on New York Stock Exchange

30 Sep 2016
Change (% chg)

$1.52 (+1.72%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Desmond-Hellmann, Susan 

Dr. Susan Desmond-Hellmann, M.D., is an Independent Director of the Procter & Gamble Company. Dr. Desmond-Hellmann is Chancellor and Arthur and Toni Rembe Rock Distinguished Professor, University of California, San Francisco (“UCSF”), where she has served since August 2009. From 2004 through 2009, Dr. Desmond-Hellmann served as president of product development at Genentech (a biotechnology company), where she was responsible for pre-clinical and clinical development, business development, and product portfolio management. Prior to joining Genentech in 1995, Dr. Desmond-Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb Pharmaceutical Research Institute. She has been a Director of Facebook Inc. since March 2013. As Chancellor of UCSF, a member of the Howard Hughes Medical Institute board of trustees, Facebook director, and past president of product development at Genentech, Dr. Desmond-Hellmann has extensive leadership and technology experience. As a former member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council, she also brings finance experience to the Board.

Basic Compensation

Total Annual Compensation, USD 110,000
Restricted Stock Awards, USD 175,000
Long-Term Incentive Plans, USD --
All Other, USD 222
Fiscal Year Total, USD 285,222

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --